LINC00314

Mutation & survival
SurvivalMutationKaplan–Meier · TCGA cohorts

Across TCGA pan-cancer cohorts, LINC00314 Mutation is linked to patient survival in 1 of 34 cancer types, making it a survival-associated LINC00314 data layer compared with 15 for mass-spec protein.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher LINC00314 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated LINC00314 expression acts as an unfavorable survival marker.

UCEC are the cancer types where LINC00314 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.
LineageMeasureSplitStageAUC1
high
AUC2
low
pSampling consensus
UCECOSMedianIII,IV0.2220.829<.00112view →
Pink = unfavorable, green = favorable. Showing the 1 strongest of 1 lineages.

LINC00314–UCEC (OS)

Kaplan–Meier survival curve for LINC00314 mutant vs wild-type samples in UCEC.

Open the UCEC breakdown →

Exploration